“showed a trend”

The results did not yield statistical significance but showed a trend in the direction opposite to the LHS.

Conclusion: Based on our experience, oral risedronate effectively decreased bone resorption, showed a trend towards decrease in fracture rate with improvement in symptoms, and was well tolerated in children with OI.

Analysis showed a trend for subjects to exhibit an increase in sleepiness across the retention interval in the sleep condition and a decrease in sleepiness across the retention interval in the wake condition (interaction before/after × wake/sleep, F 1,16 = 3.710, p = 0.072, η 2 = 0.084).

The higher concentration exposure 15 and 20 μM showed a trend which is totally different from the lower concentration exposed pattern.

While Balb/c enterocytes showed a trend of increased LIP compared to BL/6 (Figure 4e and f ), Balb/c colonocytes harbored 8‐fold more intracellular LIP (Figure 4g and h ). 3.4 Balb/c mice are more refractory to LPS‐induced hypoferremia of inflammation Hypoferremia of inflammation is a primitive, protective innate immune response that depletes circulating iron during infection and inflammation.

Secondly, the present study also suggests that the microRNA expression profiles of MSS, MSI-L and MSI-H showed a trend change in GCa tumor samples.

According to the 2018 Annual Report of Chinese Academy of Medical Sciences, the National Center for Cardiovascular Diseases, ratio of degenerative diseases has showed a trend of rising by years.

LOX2 , JI , and JI2 showed a trend towards reduced expression in transgenic lines, but differences were not consistently significant across all lines ( Supplementary Fig.

Their study also showed a trend toward the rs1478604, rs2228261, rs2228262 ACA haplotype increasing risk of rejection.

On day 17 of illness, the conjunctival swabs remained positive (Ct value: 37.67) but showed a trend of decreasing levels.

Numeric scores on pragmatic and semantic tasks showed a trend for females with TD to perform best, followed by males with TD, then females with HFASD, and finally males with HFASD tending to perform worse on all measures.

However, AIS patients treated with MT + tirofiban showed a trend towards acquiring faster functional independence, with a median time to acquire functional independence of 4.0 months compared with 6.5 months in the control group (risk ratio = 1.49, 95% confidence interval 0.98–2.27; long rank p =0.066).

Multivariate analyses integrating other regression variables showed a trend in favour of rehabilitation and revascularization therapies on recovery although did not reach statistical significance and that the positive predictors of recovery improvement were baseline BI score, time to treatment, and dietary supplement MLC901 (NurAiDTMII).

CL significantly reduced early apoptosis, and IHL showed a trend to reduce early apoptosis although not significantly.

Compared with the control (nanoparticle-free) group, the three sizes of Fe 3 O 4 -NPs, 60, 120 and 250 nm, showed a trend of increasing MDA, but the MDA levels of the three sizes were not significantly different in our study.

IgG + plasma cells also showed a trend towards increased mutational frequency in the sigmoid colon, however their numbers were limiting ( Figure 5e ).

The seroconversion rate in the EVLP group (12%) showed a trend to be lower compared to the CSP (20%) group.

The inhibitors showed a trend consistent with their corresponding IC 50 values in the bioreporter assays.

CONCLUSIONS: This exploratory analysis showed a trend toward increased hypertension, inflammatory and respiratory comorbidity, higher RVS, and previous corticosteroid treatment in patients initiating on IG compared with all PID patients.

A 24-week progressive resistance training (PRT) intervention study in people with relapsing remitting MS, showed a trend towards brain preservation in the training group.

For commercial re-use, please contact journals.permissions@oup.com Abstract Background The randomized phase II INTELLANCE-2/EORTC_1410 trial on EGFR-amplified recurrent glioblastomas showed a trend towards improved overall survival when patients were treated with depatux-m plus temozolomide compared with the control arm of alkylating chemotherapy only.

Depatux-M in combination with temozolomide showed a trend towards improved survival times compared to temozolomide/lomustine alone, with patients relapsing more than 4 months after the last adjuvant temozolomide cycle deriving the greatest benefit.

The robot showed a trend toward finding the real acetabulum and improving the cup positioning.

IL-21 + total pTfh also showed a trend for higher frequencies in P subjects compared to NP subjects post-vaccination (not shown).

KDM6A mutant cells showed a trend towards higher AraC IC 50 values compared to WT (Supplementary Fig. 7a ).